Limitations included the predominantly White and female participants, as well as normal baseline metabolic values, which may have attenuated the improvements
Examples of these drugs include: Abaloparatide (Tymlos) and Teriparatide (Forteo) for osteoporosis Carfilzomib (Kyprolis) for multiple myeloma Degarelix (Firmagon) for advanced prostate cancer Dulaglutide (Trulicity), exenatide (Byetta), liraglutide (Victoza), lixisenatide (Adlyxin), and semaglutide (Ozempic, Wegovy) for type 2 diabetes Enfuvirtide (Fuzeon) for HIV Linaclotide (Linzess) for irritable bowel syndrome (IBS) with constipation and chronic idiopathic constipation Teduglutide (Gattex) for malabsorption (when you don't absorb nutrients from your stomach and intestines very well) Ziconotide (Prialt) for severe chronic pain Unlike some cosmetics and supplements, these drugs have been well-researched and are tightly regulated by the FDA
Enhances skin thickness and density As we age, the skin becomes thinner and more fragile
19: Sikiric P, Gojkovic S, Krezic I, Smoday IM, Kalogjera L, Zizek H, Oroz K, Vranes H, Vukovic V, Labidi M, Strbe S, Baketic Oreskovic L, Sever M, Tepes M, Knezevic M, Barisic I, Blagaic V, Vlainic J, Dobric I, Staresinic M, Skrtic A, Jurjevic I, Boban Blagaic A, Seiwerth S
The Reality: DSIP Is Not an Approved Treatment DSIP is: Not FDA approved Not prescribed in addiction treatment programs Not included in clinical guidelines for opioid use disorder Even though it sounds promising on the surface, theres no strong evidence showing that DSIP can: Reduce cravings Prevent relapse Replace evidence-based treatments Its being discussed far more in online communities and experimental spaces than in real medical settings
Key Ingredients